Opinion
CRIMINAL ACTION 20-200
10-13-2022
UNITED STATES OF AMERICA v. TEVA PHARMACEUTICALS USA, INC. and GLENMARK PHARMACEUTICALS., USA
ORDER
R. BARCLAY SURRICK, J.
AND NOW, this 13th day of October 2022, upon consideration of Teva Pharmaceuticals USA, Inc.'s Motion for Disclosure of Evidence Presented to the Grand Jury as to “Other Generic Drugs” (ECF No. 153), the Government's response in opposition thereto (ECF No. 154), and all documents submitted in support thereof and in opposition thereto, it is ORDERED that Defendant's Motion is DENIED.
IT IS SO ORDERED.